EDGAR Filing Documents for 0001213900-21-016115

Form 8-K - Current report:

SEC Accession No. 0001213900-21-016115

Filing Date

2021-03-17

Accepted

2021-03-17 17:14:28

Documents

Period of Report

2021-03-12

Items

Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea137815-8k_protarathera.htm	8-K	31927
2	EXHIBIT 16.1	ea137815ex16-1_protarathera.htm	EX-16.1	3811
	Complete submission text file	0001213900-21-016115.txt		37070

Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010

Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337

Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 21751507
SIC: 2836 Biological Products, (No Diagnostic Substances)